Abstract: The last decade has witnessed significant developments in various aspects of Biomedical Informatics, including Bioinformatics, Medical Informatics, Public Health Informatics, and Biomedical ...

Equipment Failure Disrupts Newark Airport Air Traffic Control — Again Another air traffic control outage hit Newark Liberty International Airport on Sunday, May 11, as federal authorities announced ...

Another radar outage at the Philadelphia Terminal Radar Approach Control (TRACON) has triggered flight disruptions at Newark Liberty International Airport (EWR) on May 11, 2025, marking the third ...

Access detailed historical stock prices, including daily closing prices, for TCON. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

NEW YORK - The tragic, midair collision of American Eagle Flight 5342 and an Army Black Hawk helicopter near Reagan National Airport in Washington, D.C. is putting a spotlight on air traffic ...

US based deep-cycle battery manufacturer Trojan has released a series of online educational videos which provide in-depth information on a variety of battery topics as well as expanding awareness and ...

RiVAMP is a methodology set up by UNEP to identify and quantify the role of ecosystems for DRR and CCA. The pilote study on the role of ecosystems for mitigating beach erosion in Negil, Jamaica is ...

The world’s first injectable immune checkpoint inhibitor likely won’t make it to the U.S. anytime soon after the China-approved drug flunked a pivotal trial in a rare cancer, forcing its stateside ...

Tracon Pharmaceuticals Inc. is shuttering all development of its subcutaneous PD-L1 antibody, envafolimab, after the pivotal trial failed to meet the primary endpoint in soft tissue sarcoma.

TRACON Pharmaceuticals today announced that, following stockholder approval at the special meeting of stockholders held on September 6, 2023 of a proposal authorizing the board of directors of the ...

Java developers absolutely must learn Maven. Maven is the most popular and pervasive build tool in the Java world. Even if you don't use Maven directly, alternatives such as Gradle, Jenkins or Ivy ...